The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) mice-Reference-Cited by-同舟云学术

The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) mice

Published:2020-03-25 Issue:5 Volume:35 Page:793-807
ISSN:0885-7490
Container-title:Metabolic Brain Disease
language:en
Short-container-title:Metab Brain Dis

Author:

Miao Qiang,Zhang Xiao-Xue,Han Qing-Xian,Ren Si-Si,Sui Ruo-Xuan,Yu Jing-Wen,Wang Jing,Wang Qing,Yu Jie-Zhong,Cao Liang,Xiao Wei,Xiao Bao-Guo,Ma Cun-Gen

Funder

National Natural Science Foundation of China

Shanxi Scholarship Council of China

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Biochemistry

Link

http://link.springer.com/content/pdf/10.1007/s11011-020-00555-w.pdf

Reference51 articles.

1. Aboul-Enein F, Lassmann H (2005) Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol 109:49–55

2. Akdis CA, Blaser K (1999) IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 13:603–609

3. Aronson NN, Backes M, Kuranda MJ (1989) Rat liver chitobiase: purification, properties, and role in the lysosomal degradation of Asn-linked glycoproteins. Arch Biochem Biophys 272:290–300

4. Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97:742–768

5. Bevan RJ, Evans R, Griffiths L, Watkins LM, Rees MI, Magliozzi R, Allen I, McDonnell G, Kee R, Naughton M, Fitzgerald DC, Reynolds R, Neal JW, Howell OW (2018) Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Ann Neurol 84:829–842

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-HMF attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis mice by inhibiting the MIF-CD74 interaction;Acta Biochimica et Biophysica Sinica;2023-07-10

2. Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial;Vaccines;2023-02-16

3. Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models;Frontiers in Immunology;2022-05-26

4. Bilobalide: A review of its pharmacology, pharmacokinetics, toxicity, and safety;Phytotherapy Research;2021-08-02

5. Progress in the Application of Drugs for the Treatment of Multiple Sclerosis;Frontiers in Pharmacology;2021-07-13